Should we start population screening for prostate cancer? Randomised trials are still needed

Int J Cancer. 2002 Jan 20;97(3):377-8. doi: 10.1002/ijc.1621.
No abstract available

MeSH terms

  • Clinical Trials as Topic
  • Humans
  • Male
  • Mass Screening*
  • Prostate-Specific Antigen / blood
  • Prostatic Neoplasms / diagnosis*
  • Time Factors

Substances

  • Prostate-Specific Antigen